ACS Chemical Neuroscience
Scope & Guideline
Advancing Interdisciplinary Insights in Neuroscience.
Introduction
Aims and Scopes
- Neurochemical Modulation and Drug Development:
A primary focus of the journal is the exploration of neurochemical pathways and the design of pharmacological agents aimed at modulating these pathways to treat neurological disorders such as Alzheimer's, Parkinson's, and depression. - Molecular Mechanisms of Neurodegeneration:
Research articles often delve into the molecular underpinnings of neurodegenerative diseases, investigating protein aggregation, oxidative stress, and neuroinflammation as key factors in disease progression. - Innovative Therapeutic Strategies:
The journal emphasizes the development of innovative strategies for neuroprotection and neuroregeneration, including the use of small molecules, peptides, and biologics to target specific pathways involved in neuronal health. - Advanced Imaging Techniques:
Articles frequently highlight advancements in imaging modalities, such as PET and MRI, which are crucial for understanding brain function and pathology at a molecular level. - Translational Research:
The journal promotes research that bridges the gap between laboratory discoveries and clinical applications, focusing on the therapeutic potential of new compounds and their mechanisms of action.
Trending and Emerging
- Neuroinflammation and Immune Modulation:
There is a marked increase in research investigating the role of neuroinflammation in various neurological disorders, along with approaches to modulate the immune response as a therapeutic strategy. - Psychedelic Compounds and Their Therapeutic Potential:
Recent papers have highlighted the exploration of psychedelics, such as psilocybin and LSD, for their potential therapeutic effects in treating mood disorders and other neuropsychiatric conditions, indicating a resurgence of interest in this area. - Artificial Intelligence and Machine Learning Applications:
The integration of AI and machine learning in drug discovery and neuroimaging is on the rise, reflecting a trend towards computational approaches that enhance the understanding of complex neurobiological systems. - Targeted Protein Degradation Technologies:
Research on targeted protein degradation, particularly in the context of neurodegenerative diseases, is gaining momentum as a novel therapeutic strategy to eliminate toxic protein aggregates. - Gut-Brain Axis Research:
There is an increasing focus on the gut-brain axis and its implications for neurodegenerative diseases and mental health, reflecting a broader understanding of the interconnectedness of physiological systems.
Declining or Waning
- Classical Neuropharmacology:
Research focusing solely on classical neuropharmacological agents, such as traditional antidepressants or anxiolytics, seems to be losing traction as the field shifts towards more complex, multimodal approaches to treatment. - Basic Neuroanatomy Studies:
Basic studies in neuroanatomy without a clear connection to functional implications or therapeutic applications are becoming less frequent, reflecting a shift towards more integrated and applied research. - Single Target Drug Development:
The trend towards developing single-target drugs appears to be waning, as there is a growing emphasis on multitarget approaches that address the multifaceted nature of neurological disorders. - In Vitro Models with Limited Relevance:
Research relying heavily on traditional in vitro models lacking translational relevance to human physiology is decreasing, as there is a greater demand for studies utilizing more sophisticated in vivo or organoid models.
Similar Journals
Neural Regeneration Research
Exploring the frontiers of developmental neuroscience.Neural Regeneration Research is a premier Open Access journal, published by Wolters Kluwer Medknow Publications, dedicated to advancing the field of Developmental Neuroscience. Since its inception, the journal has established itself as a valuable resource for researchers, professionals, and students alike, providing a comprehensive platform for disseminating the latest findings and methodologies in neural regeneration. With an impressive Scopus Ranks placement of #3 out of 49 in its category and a Q2 Quartile ranking, the journal boasts a significant impact within the academic community, reflecting its high quality and relevance. Since adopting an Open Access model in 2011, it has expanded access to critical research in neural regeneration, fostering collaboration and innovation among scholars globally. Covering various aspects of neuroscience, its converged years from 2006 to 2025 highlight the journal's commitment to ongoing discourse and discovery. Situated in China, the journal not only promotes local insights but also connects the global research community to pressing topics in neuroscience, making it an essential read for anyone involved in this dynamic field.
ACTA NEUROBIOLOGIAE EXPERIMENTALIS
Advancing the Frontiers of NeurobiologyACTA NEUROBIOLOGIAE EXPERIMENTALIS, an esteemed journal published by the Nencki Institute of Experimental Biology in Poland, has been a pivotal platform for the dissemination of research in the fields of medicine and neuroscience since its inception in 1970. With an ISSN of 0065-1400 and an E-ISSN of 1689-0035, this journal has consistently aimed to contribute to the understanding of neurobiological phenomena, cementing its status within the academic community. Despite its current categorization in the Q3 and Q4 quartiles for Medicine and Neuroscience respectively, ACTA NEUROBIOLOGIAE EXPERIMENTALIS continues to uphold rigorous scientific standards, providing an invaluable resource for researchers, professionals, and students alike. As an essential scholarly outlet, it encourages the exploration of groundbreaking findings and clinical applications in neurobiology, making it an attractive choice for those eager to advance their understanding of this intricate field.
NEUROCHEMISTRY INTERNATIONAL
Unveiling Insights in Cellular and Molecular NeuroscienceNEUROCHEMISTRY INTERNATIONAL, published by Pergamon-Elsevier Science Ltd, offers a premier platform for researchers and professionals in the realms of cell biology and cellular and molecular neuroscience. Established in 1980 and continuing its passion for advancing the field, this esteemed journal enhances scientific collaboration with a notable 2023 Q2 ranking in both relevant categories, placing it among the top-tier publications in its discipline with a Scopus rank of 23/97 for Cellular and Molecular Neuroscience. With its focus on groundbreaking research, the journal provides a wealth of vital data and insights that drive forward our understanding of neurochemistry and its implications in health and disease. While not an Open Access journal, NEUROCHEMISTRY INTERNATIONAL is integral for professionals, academics, and students aiming to stay at the forefront of neurobiological research innovations, making significant contributions to both academia and clinical applications.
NEUROMOLECULAR MEDICINE
Driving Discovery in Neuromolecular ResearchNEUROMOLECULAR MEDICINE, published by HUMANA PRESS INC, is a prestigious peer-reviewed journal dedicated to advancing the fields of cellular and molecular neuroscience, molecular medicine, and neurology. With an ISSN of 1535-1084 and an E-ISSN of 1559-1174, the journal boasts a significant presence in academic research since its inception in 2002 and continues to publish cutting-edge studies through 2024. Ranked in the Q2 category for 2023 in various disciplines, including Neuroscience and Molecular Medicine, it holds impressive positions in Scopus rankings, including 41st out of 192 in Neuroscience and Neurology. Although not an open access journal, NEUROMOLECULAR MEDICINE remains invaluable for researchers, professionals, and students seeking to explore the intricate relationships between molecular mechanisms and neurological functions, thereby contributing to the scientific understanding of nervous system diseases and therapeutic innovations.
NeuroSci
Pioneering Discoveries in Cognitive and Neurobiological StudiesNeuroSci is an esteemed open-access journal published by MDPI, dedicated to advancing the field of neuroscience through high-quality research dissemination. Operating under the E-ISSN 2673-4087, this journal aims to foster collaboration and innovation by providing a platform for original research articles, reviews, and theoretical studies that address the complexities of the brain and nervous system. NeuroSci encourages submissions from a wide array of disciplines including cognitive neuroscience, neurobiology, neurophysiology, and neuropsychology, making it an essential resource for researchers, professionals, and students alike. With its commitment to open accessibility, NeuroSci ensures that groundbreaking findings are readily available to the global community, thereby enhancing the impact and exchange of knowledge in neuroscience. The journal is located at ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND, contributing to the reputation of MDPI as a leading publisher in the academic landscape.
JOURNAL OF CHEMICAL NEUROANATOMY
Innovating Understanding of the Brain's Chemical LandscapeJOURNAL OF CHEMICAL NEUROANATOMY, published by Elsevier, focuses on the intersection of neuroscience and chemical processes, making it an essential resource for researchers and professionals in the field. With a commitment to advancing the understanding of the cellular and molecular underpinnings of neuroanatomy, this journal has provided a platform for innovative research since its inception in 1988, with its current dissemination period extending through 2024. Operating from the Netherlands, it has earned its place in the Q3 category of cellular and molecular neuroscience as per the 2023 assessments. While it currently does not offer Open Access options, the journal remains a valuable asset in disseminating cutting-edge studies that explore the complexity of the nervous system. With its ISSN 0891-0618 and E-ISSN 1873-6300, the journal serves a diverse audience, including researchers, clinicians, and students, fostering collaboration and innovation in the ever-evolving field of neuroanatomy.
CELLULAR AND MOLECULAR NEUROBIOLOGY
Connecting Innovative Research with Neurobiological Discoveries.CELLULAR AND MOLECULAR NEUROBIOLOGY, published by SPRINGER/PLENUM PUBLISHERS, stands as a significant contributor to the fields of cell biology and neuroscience, holding a distinguished position in the academic community with an impact factor that places it in the Q2 category for both Cell Biology and Cellular and Molecular Neuroscience, along with Q1 in Medicine (miscellaneous). Since its inception in 1981, this journal has provided a critical platform for innovative research and thought-provoking reviews, fostering a deeper understanding of complex neurobiological mechanisms. The journal’s rigorous peer-review process ensures the publication of high-quality manuscripts that offer valuable insights into cellular processes and neural functions. With a commitment to advancing knowledge and promoting collaboration among researchers, CELLULAR AND MOLECULAR NEUROBIOLOGY remains an essential resource for professionals and students alike, looking to stay updated on the latest developments in neurobiology.
Frontiers in Cellular Neuroscience
Exploring cellular insights for groundbreaking discoveries.Frontiers in Cellular Neuroscience, published by FRONTIERS MEDIA SA, is an esteemed open-access journal operating out of Switzerland that has been at the forefront of disseminating cutting-edge research since its inception in 2007. With a focus on the cellular and molecular aspects of neuroscience, this journal addresses fundamental questions and advances our understanding of the nervous system, making it indispensable for researchers, professionals, and students in the field. As of 2023, it is ranked in the Q2 category for Cellular and Molecular Neuroscience, positioned at rank #27 out of 97 in Scopus, and boasting a notable 72nd percentile ranking, reflecting its impactful contributions to the discipline. The journal's commitment to open access enhances the accessibility of vital research findings, promoting knowledge sharing and collaboration. Researchers looking for a platform to publish groundbreaking neuroscience research will find Frontiers in Cellular Neuroscience an ideal venue for reaching a wide audience.
Molecular Neurodegeneration
Illuminating the pathways of neurodegeneration.Molecular Neurodegeneration is a leading journal published by BMC, dedicated to advancing the field of neurodegeneration through high-quality, open-access research. Since its inception in 2006, this peer-reviewed journal has provided a pivotal platform for the dissemination of innovative findings in the realms of Cellular and Molecular Neuroscience, Molecular Biology, and Clinical Neurology. With a stellar impact factor and listed in the prestigious Q1 category in multiple relevant categories, it ranks among the top publications in the field—specifically, it holds the #3 position in Neuroscience and #6 position in Clinical Neurology based on Scopus metrics. Researchers, professionals, and students alike will find significant value in the open access format, which fosters unrestricted sharing of knowledge, ensuring that emerging ideas in neurodegeneration reach a global audience. Based in London, United Kingdom, the journal promises a comprehensive scope that addresses critical questions in neurobiology, making it an essential resource for anyone interested in the molecular mechanisms underlying neurodegenerative diseases.
BRAIN RESEARCH BULLETIN
Bridging disciplines to enhance neuroscience knowledge.BRAIN RESEARCH BULLETIN is a leading academic journal published by PERGAMON-ELSEVIER SCIENCE LTD, dedicated to the dissemination of high-quality research in the interdisciplinary field of neuroscience. Since its inception in 1976, this journal has served as a vital platform for researchers, professionals, and students interested in a broad spectrum of topics within neuroscience, making significant contributions to the understanding of brain function and its associated disorders. With a commendable impact factor and a current Scopus rank of #35 out of 113 in general neuroscience, the journal holds a Q2 quartile ranking, underscoring its relevance and influence in the academic community. BRAIN RESEARCH BULLETIN invites submissions of original articles, reviews, and brief communications, enhancing scholarly communication within this dynamic field. Although the journal is not open access, it ensures widespread reach and impact through various subscription models, allowing access to pivotal findings that pave the way for future research advancements. For researchers aiming to share impactful discoveries and insights within the neuroscience community, BRAIN RESEARCH BULLETIN remains an essential outlet.